We hate to say ‘we told you so,’ but a recent study in the New England Journal of Medicine basically confirmed what we warned might be the case two years ago. The anti-COVID cocktail of nirmatrelvir and ritonavir, more commonly known as Paxlovid, is no more effective than placebo at combating COVID symptoms. Yes, you read that correctly . . two years have passed (and how many useless doses prescribed??) since the FLCCC told you there wasn’t enough data to determine its efficacy. Even more, we cautioned about the many drug contraindications and the rebound infections that were common with Paxlovid. You can watch Dr. Kory and Dr. Marik discussing it on a webinar in April 2022: Ask the Docs - FLCCC Alliance (covid19criticalcare.com)
Of course, Big Pharma and their media accomplices were more than happy to push this product incessantly for the past 24 months, racking up profits while the people remained sick with continuing symptoms, or worse, a rebound case (which Paxlovid is now infamous for).
